De Deyn PP

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (13)

Title : Association between low vitamin D status, serotonin and clinico-bio-behavioral parameters in Alzheimer's disease - Richter_2023_Dement.Geriatr.Cogn.Disord__
Author(s) : Richter AL , Diepeveen-de Bruin M , Balvers MGJ , De Groot L , De Deyn PP , Engelborghs S , Witkamp RF , Vermeiren Y
Ref : Dementia & Geriatric Cognitive Disorders , : , 2023
Abstract : Richter_2023_Dement.Geriatr.Cogn.Disord__
ESTHER : Richter_2023_Dement.Geriatr.Cogn.Disord__
PubMedSearch : Richter_2023_Dement.Geriatr.Cogn.Disord__
PubMedID: 37806302

Title : Pre-analytical stability of novel cerebrospinal fluid biomarkers - Willemse_2019_Clin.Chim.Acta_497_204
Author(s) : Willemse EAJ , Vermeiren Y , Garcia-Ayllon MS , Bridel C , De Deyn PP , Engelborghs S , van der Flier WM , Jansen EEW , Lopez-Font IB , Mendes V , Manadas B , de Roeck N , Saez-Valero J , Struys EA , Vanmechelen E , Andreasson U , Teunissen CE
Ref : Clinica Chimica Acta , 497 :204 , 2019
Abstract : Willemse_2019_Clin.Chim.Acta_497_204
ESTHER : Willemse_2019_Clin.Chim.Acta_497_204
PubMedSearch : Willemse_2019_Clin.Chim.Acta_497_204
PubMedID: 31348908

Title : Long-term Course of Alzheimer Disease in Patients Treated According to the Dutch Dementia Guideline at a Memory Clinic: A Real-Life Study - Droogsma_2016_Alzheimer.Dis.Assoc.Disord_30_53
Author(s) : Droogsma E , van Asselt D , van Steijn J , Diekhuis M , Veeger N , De Deyn PP
Ref : Alzheimer Disease & Associated Disorders , 30 :53 , 2016
Abstract : Droogsma_2016_Alzheimer.Dis.Assoc.Disord_30_53
ESTHER : Droogsma_2016_Alzheimer.Dis.Assoc.Disord_30_53
PubMedSearch : Droogsma_2016_Alzheimer.Dis.Assoc.Disord_30_53
PubMedID: 25756604

Title : Prolyl carboxypeptidase activity decline correlates with severity and short-term outcome in acute ischemic stroke - Kehoe_2015_Neurochem.Res_40_81
Author(s) : Kehoe K , Brouns R , Verkerk R , Engelborghs S , De Deyn PP , Hendriks D , De Meester I
Ref : Neurochem Res , 40 :81 , 2015
Abstract : Kehoe_2015_Neurochem.Res_40_81
ESTHER : Kehoe_2015_Neurochem.Res_40_81
PubMedSearch : Kehoe_2015_Neurochem.Res_40_81
PubMedID: 25370794
Gene_locus related to this paper: human-PRCP

Title : Initial cognitive response to cholinesterase inhibitors and subsequent long-term course in patients with mild Alzheimer's disease - Droogsma_2015_Int.Psychogeriatr_27_1323
Author(s) : Droogsma E , van Asselt D , Diekhuis M , Veeger N , van der Hooft C , De Deyn PP
Ref : Int Psychogeriatr , 27 :1323 , 2015
Abstract : Droogsma_2015_Int.Psychogeriatr_27_1323
ESTHER : Droogsma_2015_Int.Psychogeriatr_27_1323
PubMedSearch : Droogsma_2015_Int.Psychogeriatr_27_1323
PubMedID: 25779465

Title : Effects of Cholinesterase Inhibitors in Parkinson's Disease Dementia: A Review of Clinical Data - van Laar_2011_CNS.Neurosci.Ther_17_428
Author(s) : van Laar T , De Deyn PP , Aarsland D , Barone P , Galvin JE
Ref : CNS Neurosci Ther , 17 :428 , 2011
Abstract : van Laar_2011_CNS.Neurosci.Ther_17_428
ESTHER : van Laar_2011_CNS.Neurosci.Ther_17_428
PubMedSearch : van Laar_2011_CNS.Neurosci.Ther_17_428
PubMedID: 21951368

Title : Consistency of neuropsychiatric syndromes across dementias: results from the European Alzheimer Disease Consortium. Part II - Aalten_2008_Dement.Geriatr.Cogn.Disord_25_1
Author(s) : Aalten P , Verhey FR , Boziki M , Brugnolo A , Bullock R , Byrne EJ , Camus V , Caputo M , Collins D , De Deyn PP , Elina K , Frisoni G , Holmes C , Hurt C , Marriott A , Mecocci P , Nobili F , Ousset PJ , Reynish E , Salmon E , Tsolaki M , Vellas B , Robert PH
Ref : Dementia & Geriatric Cognitive Disorders , 25 :1 , 2008
Abstract : Aalten_2008_Dement.Geriatr.Cogn.Disord_25_1
ESTHER : Aalten_2008_Dement.Geriatr.Cogn.Disord_25_1
PubMedSearch : Aalten_2008_Dement.Geriatr.Cogn.Disord_25_1
PubMedID: 18025783

Title : Cognitive evaluation of disease-modifying efficacy of donepezil in the APP23 mouse model for Alzheimer's disease - Van Dam_2008_Psychopharmacology.(Berl)_197_37
Author(s) : Van Dam D , Coen K , De Deyn PP
Ref : Psychopharmacology (Berl) , 197 :37 , 2008
Abstract : Van Dam_2008_Psychopharmacology.(Berl)_197_37
ESTHER : Van Dam_2008_Psychopharmacology.(Berl)_197_37
PubMedSearch : Van Dam_2008_Psychopharmacology.(Berl)_197_37
PubMedID: 18008065

Title : Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease - Burn_2006_Mov.Disord_21_1899
Author(s) : Burn D , Emre M , McKeith I , De Deyn PP , Aarsland D , Hsu C , Lane R
Ref : Movement Disordersord , 21 :1899 , 2006
Abstract : Burn_2006_Mov.Disord_21_1899
ESTHER : Burn_2006_Mov.Disord_21_1899
PubMedSearch : Burn_2006_Mov.Disord_21_1899
PubMedID: 16960863

Title : Early onset effects of galantamine treatment on attention in patients with Alzheimer's disease - Vellas_2005_Curr.Med.Res.Opin_21_1423
Author(s) : Vellas B , Cunha L , Gertz HJ , De Deyn PP , Wesnes K , Hammond G , Schwalen S
Ref : Curr Med Res Opin , 21 :1423 , 2005
Abstract : Vellas_2005_Curr.Med.Res.Opin_21_1423
ESTHER : Vellas_2005_Curr.Med.Res.Opin_21_1423
PubMedSearch : Vellas_2005_Curr.Med.Res.Opin_21_1423
PubMedID: 16197661

Title : Symptomatic effect of donepezil, rivastigmine, galantamine and memantine on cognitive deficits in the APP23 model - Van Dam_2005_Psychopharmacology.(Berl)_180_177
Author(s) : Van Dam D , Abramowski D , Staufenbiel M , De Deyn PP
Ref : Psychopharmacology (Berl) , 180 :177 , 2005
Abstract : Van Dam_2005_Psychopharmacology.(Berl)_180_177
ESTHER : Van Dam_2005_Psychopharmacology.(Berl)_180_177
PubMedSearch : Van Dam_2005_Psychopharmacology.(Berl)_180_177
PubMedID: 15654502

Title : Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models - Van Dam_2005_Neurochem.Int_46_409
Author(s) : Van Dam D , Marescau B , Engelborghs S , Cremers T , Mulder J , Staufenbiel M , De Deyn PP
Ref : Neurochem Int , 46 :409 , 2005
Abstract : Van Dam_2005_Neurochem.Int_46_409
ESTHER : Van Dam_2005_Neurochem.Int_46_409
PubMedSearch : Van Dam_2005_Neurochem.Int_46_409
PubMedID: 15737439

Title : Rivastigmine for dementia associated with Parkinson's disease - Emre_2004_N.Engl.J.Med_351_2509
Author(s) : Emre M , Aarsland D , Albanese A , Byrne EJ , Deuschl G , De Deyn PP , Durif F , Kulisevsky J , van Laar T , Lees A , Poewe W , Robillard A , Rosa MM , Wolters E , Quarg P , Tekin S , Lane R
Ref : N Engl J Med , 351 :2509 , 2004
Abstract : Emre_2004_N.Engl.J.Med_351_2509
ESTHER : Emre_2004_N.Engl.J.Med_351_2509
PubMedSearch : Emre_2004_N.Engl.J.Med_351_2509
PubMedID: 15590953